Encompass Health CFO Departs, New Directors Appointed
Ticker: EHC · Form: 8-K · Filed: Mar 4, 2024 · CIK: 785161
Sentiment: neutral
Topics: executive-departure, board-election, leadership-change
Related Tickers: EHC
TL;DR
CFO out, interim CFO in, two new board members for EHC.
AI Summary
Encompass Health Corporation announced on February 27, 2024, the departure of its Chief Financial Officer, Douglas L. John, effective March 1, 2024. The company also appointed Thomas J. Virnig as interim CFO. Additionally, Encompass Health elected two new directors, Laura E. Krantz and Mark J. Yost, to its Board of Directors, effective February 27, 2024.
Why It Matters
This filing indicates a leadership change in a key financial role and an expansion of the board, which could signal strategic shifts or governance updates for the healthcare company.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding future strategy and financial management.
Key Players & Entities
- Encompass Health Corporation (company) — Registrant
- Douglas L. John (person) — Departing Chief Financial Officer
- Thomas J. Virnig (person) — Interim Chief Financial Officer
- Laura E. Krantz (person) — Newly Elected Director
- Mark J. Yost (person) — Newly Elected Director
- February 27, 2024 (date) — Date of Report and earliest event
- March 1, 2024 (date) — Effective date of CFO departure
FAQ
Who has been appointed as the interim Chief Financial Officer of Encompass Health Corporation?
Thomas J. Virnig has been appointed as the interim Chief Financial Officer.
When is the departure of Douglas L. John as CFO effective?
The departure of Douglas L. John as CFO is effective March 1, 2024.
How many new directors were elected to Encompass Health's Board?
Two new directors, Laura E. Krantz and Mark J. Yost, were elected.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated February 27, 2024.
What is the principal executive office address for Encompass Health Corporation?
The principal executive office address is 9001 Liberty Parkway, Birmingham, Alabama 35242.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 15.7 · Accepted 2024-03-04 17:28:22
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share EHC New York Stock Exchange
- $5,170,000 — on of his performance, an increase from $5,170,000 to $5,425,000 in the target long-term i
- $5,425,000 — ormance, an increase from $5,170,000 to $5,425,000 in the target long-term incentive oppor
- $550,000 — The Committee approved an increase from $550,000 to $625,000 in the annual base salary f
- $625,000 — e approved an increase from $550,000 to $625,000 in the annual base salary for Mr. Patri
- $468,750 — tunity Target TDC Opportunity $625,000 $468,750 $1,031,250 $2,125,000 SIGNATURES Pur
- $1,031,250 — rget TDC Opportunity $625,000 $468,750 $1,031,250 $2,125,000 SIGNATURES Pursuant to th
- $2,125,000 — portunity $625,000 $468,750 $1,031,250 $2,125,000 SIGNATURES Pursuant to the requireme
Filing Documents
- ehc-20240227.htm (8-K) — 25KB
- 0000785161-24-000012.txt ( ) — 149KB
- ehc-20240227.xsd (EX-101.SCH) — 2KB
- ehc-20240227_lab.xml (EX-101.LAB) — 24KB
- ehc-20240227_pre.xml (EX-101.PRE) — 12KB
- ehc-20240227_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENCOMPASS HEALTH CORPORATION By: / S / Patrick Darby Name: Patrick Darby Title: Executive Vice President, General Counsel and Secretary Dated: March 1, 2024